Clinical Trials Logo

Urinary Incontinence clinical trials

View clinical trials related to Urinary Incontinence.

Filter by:

NCT ID: NCT02731339 Completed - Clinical trials for Urinary Incontinence

Spinal Curvature, Mobility, and Low Back Pain Relationship in Women With and Without Urinary Incontinence

Start date: March 2015
Phase: N/A
Study type: Interventional

The aim of this study was to investigate the relationship among sagittal spinal curvatures, mobility, and low back pain in women with and without urinary incontinence.

NCT ID: NCT02678377 Completed - Clinical trials for Stress Urinary Incontinence

The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence

Start date: February 2016
Phase: Phase 4
Study type: Interventional

This double-blind randomized controlled trial seeks to find a better treatment for women with mixed urinary incontinence (both stress and urgency incontinence). The primary aim is to determine whether midurethral sling surgery combined with injections of onabotulinumtoxinA (Botox®) into the detrusor muscle of the bladder improves symptoms of mixed urinary incontinence better than sling surgery alone.

NCT ID: NCT02677753 Completed - Clinical trials for Urinary Incontinence

Percutaneous Nerve Evaluation With Fluoroscopy Versus Without

Start date: April 2016
Phase: N/A
Study type: Interventional

The investigators propose a randomized control trial comparing the rate of implantation of the InterStim device following Percutaneous Nerve Evaluation (PNE) performed with or without fluoroscopic guidance.

NCT ID: NCT02676700 Completed - Clinical trials for Urinary Stress Incontinence

Pelvic Floor Muscle Training and Kaatsu Training for Women With Stress Urinary Incontinence

Start date: February 2016
Phase: N/A
Study type: Interventional

This study examines the effect of adding so called Kaatsu training to pelvic floor muscle training. Half the participants will perform Kaatsu training on their thigh muscles followed by pelvic floor muscle training. The other half will receive pelvic floor muscle training alone.

NCT ID: NCT02671747 Completed - Clinical trials for Urinary Incontinence

Pilot: Mind Over Matter: Healthy Bowels, Healthy Bladder

Start date: August 2015
Phase: N/A
Study type: Interventional

The study is to pilot-test an innovative, combined urinary/bowel continence workshop in two Wisconsin communities. Between 8-15 women with incontinence will be enrolled in each of the two pilot communities and will complete three 90-minute workshop sessions over a 6 week period.

NCT ID: NCT02658448 Completed - Clinical trials for Stress Urinary Incontinence

GTx-024 as a Treatment for Stress Urinary Incontinence in Women

Start date: January 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether GTx-024 is safe and effective in the treatment of stress urinary incontinence in postmenopausal women.

NCT ID: NCT02645136 Completed - Prostate Cancer Clinical Trials

The Effects of Pilates in Muscle Strength of the Pelvic Floor as Treatment of Post Prostatectomy Urinary Incontinence

Start date: January 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the efficacy between a Pilates exercise program and a Pelvic Floor Muscle Training (PFMT) protocol combined with anal electrical stimulation (AES) in muscular pressure strength of the pelvic floor as conservative treatment of urinary incontinence after prostatectomy.

NCT ID: NCT02623842 Completed - Clinical trials for Urinary Incontinence

Radiofrequency Non-ablation in the Treatment of Women With Urinary Stress Incontinence: Study Pilot

Start date: July 2013
Phase: Phase 1
Study type: Interventional

Pilot study, case series conducted in women with a clinical diagnosis of urinary incontinence and were treated with radiofrequency technique for capacitive transfer non ablative in external urethral meatus. All participants did an hour Pad Test. The participants made five sessions of Radio Frequency (RF) with an interval of seven days between them. The application of RF was performed by physical therapist trained in the technique of radio frequency through the Tonederm® brand device with capacitive transfer method using non-ablative handle with electrode in the region of the external urethral meatro and coupling electrode placed on the participant's back. For application, the participants were in gynecological position. The session had an average duration of 20 minutes. The temperature was measured by an infrared thermometer when it reached 41graus radiofrequency was maintained for 2 minutes.

NCT ID: NCT02621736 Completed - Nocturnal Enuresis Clinical Trials

Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN).

COMEN
Start date: January 1, 2016
Phase:
Study type: Observational

Monosymptomatic nocturnal enuresis (MEN) is a common problem in children, affecting 7-10% of all 7 year olds. MEN is often leading to psychosocial problems because of its burden and stigmatism. The only available medical treatment option is the vasopressin analogum Desmopressin®. However, according to the literature, only one third of patients shows a good treatment response, defined as more than 90% of reduced bed wetting. Furthermore, treatment with Desmopressin® may lead to psychosocial problems, high costs and potentially dangerous side effects like water intoxication and hypertension. Copeptin, mirroring arginine vasopressin (AVP), has been shown to be significantly lower in patients with MEN compared to controls and lower in patients with severe bed wetting compared to patients with only slight bed wetting.

NCT ID: NCT02617472 Completed - Clinical trials for Stress Urinary Incontinence

Effectiveness of Kegel Exercise Device in Strengthening Pelvic Floor and Treating Urinary Incontinence (UI)

Start date: November 2015
Phase: N/A
Study type: Interventional

This study will assess the effectiveness of a new pelvic floor exercise device in strengthening pelvic floor muscles and treating urinary incontinence among women who are experiencing symptoms of pelvic floor weakness. The study will be conducted over 12 weeks and results will be collected through self-assessment questionnaires and clinical pelvic examination. Effectiveness outcomes will be tracked over the duration of the trial and measured against historical symptoms.